| 11525007 |
Antibody fab and Fc variants |
Peter Bruenker, Frank Herting, Sylvia Herter, Christian Klein, Tilman Schlothauer |
2022-12-13 |
| 11459404 |
Bispecific T cell activating antigen binding molecules |
Marina BACAC, Peter Bruenker, Christiane Neumann, Christian Klein, Pablo Umana +1 more |
2022-10-04 |
| 11440971 |
Fc-region variants with modified FcRn-binding and methods of use |
Tilman Schlothauer |
2022-09-13 |
| 11365232 |
Interleukin-2 fusion proteins and uses thereof |
Ralf Hosse, Christian Klein, Laurence B. Peterson, Pablo Umana, Linda Wicker |
2022-06-21 |
| 11332545 |
Anti-FAP antibodies and methods of use |
Marina BACAC, Anne Freimoser-Grundschober, Ralf Hosse, Christian Klein, Valeria G. Nicolini +1 more |
2022-05-17 |
| 11306154 |
Methods of treating cancer by administering antigen-binding molecules comprising a TNF family ligand trimer |
Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +4 more |
2022-04-19 |
| 11286300 |
Humanized anti-human CD19 antibodies and methods of use |
Claudia Ferrara Koller, Guy Georges, Alexander Haas, Hubert Kettenberger, Tilman Schlothauer +2 more |
2022-03-29 |
| 11267903 |
Antigen-binding molecules comprising a tumor necrosis factor (TNF) family ligand trimer |
Maria Amann, Peter Bruenker, Christina Claus, Claudia Ferrara Koller, Sandra Grau-Richards +4 more |
2022-03-08 |
| 11214622 |
Antibodies specific for DR5 and methods of use |
Peter Bruenker, Sherif Daouti, Ningping Feng, Claudia Ferrara Koller, Guy Georges +13 more |
2022-01-04 |
